Akebia Therapeutics, Inc 10-K for FY2023
Akebia Therapeutics, Inc. (AKBA)
10-K
2024-03-14
For: 2023-12-31
View Original
Added on
April 11, 2026
About this 10-K
Akebia Therapeutics, Inc filed this 10-K on March 14, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $194.62M
- down 33.5% from $292.48M a year earlier
- Net loss
- $51.93M
- compared with a net loss of $94.23M a year earlier
- Diluted EPS
- -$0.28
- compared with -$0.52 a year earlier